Videos

Nathan L. Scott, M.D., discusses the risk of recurrence within diagnosed uveal melanoma patients. Uveal Melanoma Prognosis and Risk Stratification

Nathan L. Scott, M.D., details what tests a patient should expect if they wish to confirm a uveal melanoma diagnosis. This program was made possible with support from Immunocore.

Melody Burchett discusses how she educates patients who have been recently diagnosed with uveal melanoma. Resources for Patients With Newly Diagnosed Uveal Melanoma

Melody Burchett discusses her journey with uveal melanoma and the formation of A Cure in Sight. This program was made possible with support from Immunocore.

After a brief introduction, Nathan L. Scott, M.D., gives an overview of uveal melanoma, including the risk factors and ways to help prevent it. This program was made possible with support from Immunocore.

Experts on chronic myeloid leukemia delve into the important role of informed shared decision-making in the optimal treatment of patients with CML.

Jorge E. Cortes, MD, details clinical scenarios that indicate a need to switch therapies for patients with chronic myeloid leukemia.

Claire Saxton shares insights on how physicians and caregivers can best assist patients with CML who have switched therapies.

A panel of experts on chronic myeloid leukemia discuss common patient concerns, adverse effect considerations, and best practices for setting clear expectations.

Walking up and down the street a few times a day can help prevent patients with kidney or bladder cancers from becoming deconditioned.

Join us for an Educated Patient® Webinar to explore the essential aspects of radiotherapy as a treatment for cancer, in addition to its various types and practical advice on managing side effects.

Focusing on the initiation of treatment for newly diagnosed patients with CML, Jorge E. Cortes, MD, details important factors to consider when starting treatment and Claire Saxton discusses strategies that optimize communication when considering treatment options.

Experts on chronic myeloid leukemia discuss how caregivers can collaborate with the health care team and support newly diagnosed patients.

Interventions, such as speech therapy, after receiving radioactive iodine treatment for thyroid cancer may help manage quality of life.

Patients with blood cancer who undergo CAR-T cell therapy should monitor for fever and signs of respiratory distress, an expert said.

Joannie Clements, a patient advocate, provides insights on helping newly diagnosed patients with CML and their caregivers navigate the complexities of diagnosis, and Claire Saxton outlines resources available for them.

A panel of experts on introduce a discussion on chronic myeloid leukemia (CML) with an overview of the disease, focusing on its subtypes and characteristics.

One expert explains what patients with prostate cancer interested in clinical trial participation need to know.

A radiation oncology nurse explains the spectrum of side effects that can come with radiation for prostate cancer.

One radiation oncologist describes the advantages of MRI-guided SBRT when treating patients with prostate cancer.

While adherence to germline testing has been found to be low, one expert explained why tests findings could matter to patients.

As part of our “Speaking Out” video series, we look at the association between prostate cancer and mental health.

When faced with scanxiety, one technique Annie Bond uses is yoga breathing exercises to help “breathe through it and just get through the moment.”

Dana Frost, a cancer survivor and grief advocate, said writing about survivors’ guilt and connecting with others feeling the same way was therapeutic.

Patients with TGCT are encouraged to honestly discuss their pain with their care teams.

One expert explains the importance of a multidisciplinary care team for patients with TGCT.

TGCT is a non-malignant tumor, but one expert explained how it can similarly affect patients.

Tenosynovial giant cell tumors are not malignant but can impact patients’ quality of life, as one expert explained.

Systemic therapy and active surveillance can be viable options for patients with TGCT, as one expert explained.

Talking about the good, bad and ugly aspects of cancer on social media is “the most healing part of this community,” a survivor said.